Israel-based quantum software startup Classiq has collaborated with South Korean-based quantum company Quantum Intelligence Corp (QIC) to speed up drug development using quantum computing in pharmacology.
The partnership will merge Classiq’s quantum computing platform with QIC’s drug development platform QUEST-ADMET, which combines quantum computing and AI, to predict the properties of drug compounds for safety and efficacy assessments.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.